Volume | 165,598 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | 2.2599 | Mínimo Máximo |
|||||
Minimo del Dia | 2.06 |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
iBio Inc | IBIO | AMEX | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
2.25 | 2.06 | 2.2599 | 2.215 | 2.25 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
---|---|---|---|---|---|
870 | 165,598 | US$ 2.14 | US$ 354,228 | - | 1.0214 - 19.00 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
17:18:58 | 1 | US$ 2.23 | USD |
Información Financiera iBio Inc IBIO
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
7.7M | 3.48M | - | 0 | -65.01M | -18.66 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre iBio Inc IBIO
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
20/5/2024 | 05:55 | Edgar (US Regulatory) | Form 8-K - Current report |
13/5/2024 | 15:32 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
13/5/2024 | 15:30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
13/5/2024 | 15:14 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
13/5/2024 | 15:08 | Edgar (US Regulatory) | Form 8-K - Current report |
13/5/2024 | 15:05 | GlobeNewswire Inc. | iBio Reports Fiscal Third Quarter 2024 Financial Results and.. |
27/3/2024 | 06:00 | GlobeNewswire Inc. | iBio and AstralBio Announce Transformative AI drug discovery.. |
26/3/2024 | 18:35 | GlobeNewswire Inc. | iBio Announces $15.0 Million Private Placement |
26/2/2024 | 06:59 | Edgar (US Regulatory) | Form 8-K - Current report |
26/2/2024 | 06:45 | GlobeNewswire Inc. | iBio Announces Sale of Preclinical PD-1 Agonist Antibody.. |
21/2/2024 | 15:55 | Edgar (US Regulatory) | Form 8-K - Current report |
19/1/2024 | 15:36 | Edgar (US Regulatory) | Form 8-K - Current report |
Histórico de Datos IBIO
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.90 | 2.47 | 1.80 | 2.17 | 335,526 | 0.34 | 17.89% |
1 Month | 1.87 | 2.47 | 1.64 | 1.99 | 202,945 | 0.37 | 19.79% |
3 Months | 1.22 | 4.98 | 1.05 | 3.43 | 4,075,175 | 1.02 | 83.61% |
6 Months | 5.604 | 6.122 | 1.0214 | 3.34 | 2,062,942 | -3.36 | -60.03% |
1 Year | 18.80 | 19.00 | 1.0214 | 4.75 | 1,296,484 | -16.56 | -88.09% |
3 Years | 30.00 | 73.20 | 1.0214 | 15.18 | 2,138,374 | -27.76 | -92.53% |
5 Years | 15.40 | 157.00 | 1.00 | 36.25 | 6,829,761 | -13.16 | -85.45% |